Sexual desire/interest disorder is absence of or a decrease in sexual interest, desire, sexual thoughts, and fantasies and absence of responsive desire. In sexual
Both Phase 3 Reconnect Studies of bremelanotide for hypoactive sexual desire disorder (HSDD) in premenopausal women met the pre-specified co-primary efficacy
Female sexual complaints are common, occurring in approximately 40 percent of women. Decreased desire is the most common complaint. Normal versus abnormal sexual
a leading developer of first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men, and CKD
The FDA have approved the first ever drug to treat low sexual desire in premenopausal women. Flibanserin – brand name Addyi – will be available from mid-October.
Flibanserin (Addyi) is labeled for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It is a nonhormonal
Why Women Lose Interest in Sex. Loss of sexual desire is women’s biggest sexual problem, and it’s not all in their heads.
Explore the latest in how decreased desire at menopause may affect sexuality. The North American Menopause Society (NAMS) provides resources for women to gain an
Hypoactive sexual desire disorder (HSDD) refers to a woman’s chronic or ongoing lack of interest in sex, to the point that it causes her personal distress or